Using our AI model trained on historical data, we generated a 12‑month forecast for Keros Therapeutics Inc. (KROS) stock. The model estimates a median target price of 0—ranging from a low of 0 to a high of 0—which suggests a decrease of 0% compared to the current price of 11.26.